Cardiolipin Enhances Protein C Pathway Anticoagulant Activity
- 30 April 2000
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 26 (2) , 115-123
- https://doi.org/10.1006/bcmd.2000.0285
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein CJournal of Clinical Investigation, 1999
- Thrombogenic Mechanisms of Antiphospholipid AntibodiesThrombosis and Haemostasis, 1997
- On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.Journal of Clinical Investigation, 1995
- Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulinBiochemical Journal, 1994
- The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein CEuropean Journal of Biochemistry, 1992
- Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).Journal of Clinical Investigation, 1992
- The Regulation of Natural Anticoagulant PathwaysScience, 1987
- Plasma protein S deficiency in familial thrombotic diseaseBlood, 1984
- INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANTThe Lancet, 1983
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981